Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22092032 | 1.00 | SLC1A3 (0.42) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL6749224 | 1.00 | SLC1A3 (0.42) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL2300063 | 0.89 | LTA4H (0.44) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL17019229 | 0.87 | RRM1 (0.44) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL31645502 | 0.87 | RRM1 (0.44) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL17006012 | 0.87 | RRM1 (0.44) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL27129437 | 0.84 | TSHR (0.39) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL27032261 | 0.84 | TSHR (0.39) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL27032110 | 0.84 | TSHR (0.39) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 | |
| SCHEMBL647500 | 0.84 | TRPA1 (0.48) | SLC1A3SLC1A2SLC1A1MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020058017-A1 | Hair cosmetic compositions | KAO CORPORATION (JP) | 2002-05-16 | — | — | US | claimed |
| EP-1190696-A2 | Hair cosmetic compositions and use thereof | Kao Corporation (JP) | 2002-03-27 | — | — | EP | claimed |
| US-20250171427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2025-05-29 | — | — | US | disclosed |
| WO-2025104230-A1 | BENZOXAZOLES AS MODULATORS OF IL-17A | SANOFI (FR) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025096771-A1 | MODULATORS OF BCL6 AS LIGAND DIRECTED DEGRADERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-3634430-B1 | MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2024-08-07 | — | — | EP | disclosed |
| US-20240246992-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | SERVIER LAB (FR) | 2024-07-25 | — | — | US | disclosed |
| CN-118184532-A | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| US-20240180941-A1 | ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2024-06-06 | — | — | US | disclosed |
| CN-113454058-B | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-03-22 | — | — | CN | disclosed |
| WO-2024054955-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| WO-2007079862-A1 | NOVEL, ACYCLIC SUBSTITUTED FUROPYRIMIDINE DERIVATIVES AND USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES | BAYER HEALTHCARE AG (DE) | 2007-07-19 | — | — | WO | disclosed |
| CN-1853603-A | Stable composition for hair dye comprising a fragrance | TAKASAGO PERFUMERY CO LTD (JP) | 2006-11-01 | — | — | CN | disclosed |
| EP-1714637-A2 | Stable composition for hair dye comprising a fragrance | Takasago International Corporation (JP) | 2006-10-25 | — | — | EP | disclosed |
| US-20060218730-A1 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| US-20020058017-A1 | Hair cosmetic compositions | KAO CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1190696-A2 | Hair cosmetic compositions and use thereof | Kao Corporation (JP) | 2002-03-27 | — | — | EP | disclosed |
| EP-0890355-B1 | Hair treatment composition | KAO CORP (JP) | 2001-05-30 | — | — | EP | disclosed |
| US-6071504-A | GUANIDIUM SALT, AMINO-MODIFIED POLYSILOXANE; ODORLESS, SKIN SENSITIVITY | KAO CORPORATION (JP) | 2000-06-06 | — | — | US | disclosed |
| EP-0890355-A1 | Hair treatment composition | Kao Corporation (JP) | 1999-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246992-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | LRRK2, PARK7, PINK1 | SLC1A3 1871/4885SLC1A2 1782/4885SLC1A1 1976/4885 |
| US-20240180941-A1 | ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE | FABP1, PYGL, LIPC | SLC1A3 2178/4885SLC1A2 1783/4885SLC1A1 1953/4885 |
| US-20250171427-A1 | THERAPEUTIC COMPOUNDS | IL17A, IL2, IL36G | SLC1A3 4645/4885SLC1A2 4363/4885SLC1A1 4423/4885 |
| US-20020058017-A1 | Hair cosmetic compositions | FHIT, MITF, HNMT | SLC1A3 214/4885SLC1A2 159/4885SLC1A1 249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.